Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn

Table of Contents

March 01, 1989; Volume 35,Issue 3
  • You have access
    Corticosterone increases protein tyrosine kinase activity in the locus coeruleus and other monoaminergic nuclei of rat brain.
    E J Nestler, R Z Terwilliger and E Halm
    Molecular Pharmacology March 1989, 35 (3) 265-270;
  • You have access
    Role of differential drug uptake, efflux, and binding of etoposide in sensitive and resistant human tumor cell lines: implications for the mechanisms of drug resistance.
    P M Politi and B K Sinha
    Molecular Pharmacology March 1989, 35 (3) 271-278;
  • You have access
    Coinduction of multiple hepatic cytochrome P-450 proteins and their mRNAs in rats treated with imidazole antimycotic agents.
    K A Hostetler, S A Wrighton, D T Molowa, P E Thomas, W Levin and P S Guzelian
    Molecular Pharmacology March 1989, 35 (3) 279-285;
  • You have access
    Cerebral muscarinic acetylcholine receptors interact with three kinds of GTP-binding proteins in a reconstitution system of purified components.
    K Haga, H Uchiyama, T Haga, A Ichiyama, K Kangawa and H Matsuo
    Molecular Pharmacology March 1989, 35 (3) 286-294;
  • You have access
    Beta 1- and beta 2-adrenergic receptor-mediated adenylate cyclase stimulation in nonfailing and failing human ventricular myocardium.
    M R Bristow, R E Hershberger, J D Port, W Minobe and R Rasmussen
    Molecular Pharmacology March 1989, 35 (3) 295-303;
  • You have access
    Beta-adrenergic desensitization reduces the sensitivity of adenylate cyclase for magnesium in permeabilized lymphocytes.
    R D Feldman
    Molecular Pharmacology March 1989, 35 (3) 304-310;
  • You have access
    Receptor glycosylation regulates the affinity of histamine H1 receptors during smooth muscle cell differentiation.
    M Mitsuhashi and D G Payan
    Molecular Pharmacology March 1989, 35 (3) 311-318;
  • You have access
    The tremorigen aflatrem is a positive allosteric modulator of the gamma-aminobutyric acidA receptor channel expressed in Xenopus oocytes.
    Y Yao, A B Peter, R Baur and E Sigel
    Molecular Pharmacology March 1989, 35 (3) 319-323;
  • You have access
    [3H]idazoxan and some other alpha 2-adrenergic drugs also bind with high affinity to a nonadrenergic site.
    M C Michel, O E Brodde, B Schnepel, J Behrendt, R Tschada, H J Motulsky and P A Insel
    Molecular Pharmacology March 1989, 35 (3) 324-330;
  • You have access
    Detection of nerve growth factor and epidermal growth factor-regulated protein kinases in PC12 cells with synthetic peptide substrates.
    L E Heasley and G L Johnson
    Molecular Pharmacology March 1989, 35 (3) 331-338;
  • You have access
    Differential effects of heparin on inositol 1,4,5-trisphosphate binding, metabolism, and calcium release activity in the bovine adrenal cortex.
    G Guillemette, S Lamontagne, G Boulay and B Mouillac
    Molecular Pharmacology March 1989, 35 (3) 339-344;
  • You have access
    Interactions of full and partial agonists with HT29 cell alpha 2-adrenoceptor: comparative study of [3H]UK-14,304 and [3H]clonidine binding.
    H Paris, J Galitzky and J M Senard
    Molecular Pharmacology March 1989, 35 (3) 345-354;
  • You have access
    The relationship between inositol trisphosphate receptor density and calcium release in brain microsomes.
    S K Joseph and H L Rice
    Molecular Pharmacology March 1989, 35 (3) 355-359;
  • You have access
    N-methyl-D-aspartate/glycine and quisqualate/kainate receptors expressed in Xenopus oocytes: antagonist pharmacology.
    T A Verdoorn, N W Kleckner and R Dingledine
    Molecular Pharmacology March 1989, 35 (3) 360-368;
  • You have access
    Release of nonmitochondrial sequestered Ca2+ from permeabilized muscle cells in culture.
    S K Ambler and P Taylor
    Molecular Pharmacology March 1989, 35 (3) 369-374;
  • You have access
    Ketanserin reduces a particular monoamine pool in peripheral tissues.
    J E Leysen, J Wynants, A Eens and P A Janssen
    Molecular Pharmacology March 1989, 35 (3) 375-380;
  • You have access
    Role of hormone-sensitive low Km cAMP phosphodiesterase in regulation of cAMP-dependent protein kinase and lipolysis in rat adipocytes.
    C J Smith and V C Manganiello
    Molecular Pharmacology March 1989, 35 (3) 381-386;
Back to top
PreviousNext

In this issue

Molecular Pharmacology
Vol. 35, Issue 3
1 Mar 1989
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts
  • Most Cited
  • Most Read
Loading
  • SB-431542 Is a Potent and Specific Inhibitor of Transforming Growth Factor-β Superfamily Type I Activin Receptor-Like Kinase (ALK) Receptors ALK4, ALK5, and ALK7
  • The G-Protein-Coupled Receptors in the Human Genome Form Five Main Families. Phylogenetic Analysis, Paralogon Groups, and Fingerprints
  • Pharmacological Properties of Y-27632, a Specific Inhibitor of Rho-Associated Kinases
  • Pharmacological characterization of five cloned voltage-gated K+ channels, types Kv1.1, 1.2, 1.3, 1.5, and 3.1, stably expressed in mammalian cell lines.
  • The Orphan Human Pregnane X Receptor Mediates the Transcriptional Activation of CYP3A4 by Rifampicin through a Distal Enhancer Module
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics